The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke

Publisher： Karger

E-ISSN： 1421-9786|13|2|120-126

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.13, Iss.2, 2002-02, pp. : 120-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocysteine-Lowering Therapy and Risk of Recurrent Stroke, Myocardial Infarction and Death: The Impact of Age in the VISP Trial

By  

Cerebrovascular Diseases, Vol. 37, Iss. 4, 2014-04 ,pp. : 263-267

Karger

Access to resources Recommend Favorite

Sustained Homocysteine-Lowering Effect over Time of Folic Acid-Based Multivitamin Therapy in Stroke Patients despite Increasing Folate Status in the Population

By  

Cerebrovascular Diseases, Vol. 19, Iss. 2, 2005-02 ,pp. : 110-116

Karger

Access to resources Recommend Favorite

Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH): Study Design and Baseline Data

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 253-261

Karger

Access to resources Recommend Favorite

Apolipoproteins as Predictors of Ischaemic Stroke in Patients with a Previous Transient Ischaemic Attack

By  

Cerebrovascular Diseases, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 323-328

Karger

Access to resources Recommend Favorite

Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke Trial

By  

Neuroepidemiology, Vol. 24, Iss. 3, 2005-04 ,pp. : 123-128

Karger

Access to resources Recommend Favorite